CRH plc · CRH · FY2026 Q1 · Calendar Q2 2026
CRH Q1 2026: Revenue Up 9%, EBITDA Up 18% as Water Infrastructure Push Deepens
CRH opened FY2026 with broad-based strength: Q1 revenue rose 9% to $7.4 billion and adjusted EBITDA grew 18% to $586 million, beating consensus revenue estimates by 4.3%. The quarter featured aggressive portfolio reshaping — $1.9 billion of non-core divestitures (Lawn & Garden, MoistureShield, and a third business) paired with $900 million of acquisitions anchored by the ~$700 million Axius Water purchase, which deepens CRH's U.S. water-quality platform. Management reaffirmed full-year adjusted EBITDA guidance of $8.1–$8.5 billion, raised the dividend 5% to $0.39 per share, and launched a $300 million share-buyback tranche. The stock initially rose 4.4% on results but has since drifted approximately 8% lower, leaving it at $102.11 — roughly 27% below the analyst consensus target of $139.15. The gap reflects robust near-term execution against investor uncertainty about IIJA…
Company context
Snapshot as of publicationCRH plc, together with its subsidiaries, provides building materials solutions in Ireland, the United States, the United Kingdom, rest of Europe, and internationally. It operates through three segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions. The company offers building materials for the construction and maintenance of public infrastructure, and commercial and residential buildings, as well as construction and renovation of transportation infrastructure, critical utility networks, commercial and residential buildings, and outdoor living spaces; paving and construction services; and produces and sells aggregates, cementitious materials, ready mixed concrete and mortars, and asphalt.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 8, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 26, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 3, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Mar 2, 2026 |
| UBS | Buy | Buy | Maintain | Jan 8, 2026 |
| Citigroup | Buy | Buy | Maintain | Jan 8, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Nov 12, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Nov 7, 2025 |
| Barclays | Overweight | Overweight | Maintain | Oct 20, 2025 |
| Truist Securities | Buy | Buy | Maintain | Oct 2, 2025 |
| Bernstein | Outperform | Outperform | Maintain | Sep 11, 2025 |
| Stifel | Hold | Buy | Downgrade | Apr 15, 2024 |
| Redburn Partners | Buy | Neutral | Upgrade | Jan 3, 2023 |
| Berenberg | Hold | Hold | Maintain | Jan 14, 2021 |
| Canaccord Genuity | Buy | Hold | Upgrade | Nov 2, 2016 |
| Societe Generale | Hold | Buy | Downgrade | Aug 26, 2016 |
| Bank of America | Neutral | Underperform | Upgrade | Apr 25, 2016 |
| B of A Securities | Neutral | Underperform | Upgrade | Apr 24, 2016 |
| HSBC | Buy | Hold | Upgrade | Jan 27, 2016 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 15, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $100.06. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $132 | $106.21 | +31.9% | Jul 8, 2026 |
| Jefferies | Analyst unavailable | $165.6 | $113.05 | +65.5% | Jun 26, 2026 |
| Morgan Stanley | Angel Castillo | $139 | $116.19 | +38.9% | Apr 15, 2026 |
| D.A. Davidson | Analyst unavailable | $120 | $125.17 | +19.9% | Feb 20, 2026 |
| Wells Fargo | Analyst unavailable | $133 | $122.46 | +32.9% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $138 | $131.38 | +37.9% | Jan 13, 2026 |
| UBS | Analyst unavailable | $147 | $122.76 | +46.9% | Jan 8, 2026 |
| Morgan Stanley | Angel Castillo | $140 | $123.68 | +39.9% | Dec 10, 2025 |
| Deutsche Bank | Analyst unavailable | $139 | $119.49 | +38.9% | Dec 8, 2025 |
| Barclays | Adam Seiden | $131 | $117.46 | +30.9% | Oct 20, 2025 |
| UBS | Julian Radlinger | $138 | $117.54 | +37.9% | Oct 14, 2025 |
| Morgan Stanley | Analyst unavailable | $134 | $117.85 | +33.9% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $135 | $116.34 | +34.9% | Oct 7, 2025 |
| UBS | Analyst unavailable | $140 | $121.1 | +39.9% | Oct 2, 2025 |
| UBS | Analyst unavailable | $152 | $119.9 | +51.9% | Oct 1, 2025 |
| RBC Capital | Anthony Codling | $108 | $85.78 | +7.9% | Apr 14, 2025 |
| Berenberg Bank | Analyst unavailable | $120 | $102.52 | +19.9% | Feb 28, 2025 |
| Truist Financial | Keith Hughes | $110 | $82.79 | +9.9% | Aug 9, 2024 |
| Morgan Stanley | Cedar Ekblom | $88 | $74.23 | -12.1% | Jul 9, 2024 |
| Truist Financial | Keith Hughes | $100 | $83.44 | -0.1% | May 13, 2024 |
| Truist Financial | Keith Hughes | $81 | $67.5 | -19.0% | Dec 14, 2023 |
Track every rating change on CRH the moment it posts. Free to start.
Start freeMarket reaction
close-to-close (session unavailable)Follow CRH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q1 revenue grew 9% year-over-year to $7.4 billion (versus consensus $7.07 billion, a 4.3% beat) and adjusted EBITDA rose 18% to $586 million. EPS came in at -$0.27 versus an estimated -$0.22, a 23.5% miss driven by the seasonal loss quarter and portfolio restructuring costs. CRH executed $1.9 billion of divestitures (Lawn & Garden, MoistureShield, and one other non-core business) and $900 million of acquisitions, highlighted by the ~$700 million Axius Water deal. The winter-fill program — storing roughly half of annual liquid asphalt needs off-season — was detailed as a structural cost advantage. Full-year adjusted EBITDA guidance was maintained at $8.1–$8.5 billion.
Guidance delta
Full-year FY2026 adjusted EBITDA guidance was reaffirmed at $8.1–$8.5 billion, unchanged from the prior quarter. Guidance sentiment was characterized as maintained. The dividend was increased 5% to $0.39 per share and a $300 million share-buyback tranche was announced, consistent with the prior quarter's capital-return framework. Capex outlook remains increasing, with plans to deploy up to $40 billion of financial capacity over five years across four growth platforms.
Key takeaways
- Q1 revenue grew 9% to $7.4 billion, beating consensus by 4.3%; adjusted EBITDA rose 18% to $586 million.
- Portfolio reshaping: $1.9 billion of non-core divestitures and $900 million of acquisitions, led by the ~$700 million Axius Water purchase to expand U.S. water-quality capabilities.
- Full-year adjusted EBITDA guidance of $8.1–$8.5 billion maintained; dividend raised 5% to $0.39; $300 million buyback tranche launched.
- Infrastructure demand megatrends — transportation, water, and reindustrialization — continue to underpin robust backlogs and pricing momentum.
- Energy cost volatility is mitigated by a mature hedging program; other input inflation expected at mid-single-digit levels.
Management priorities
- Integrate Axius Water and capture synergies across the expanded water-quality platform.
- Deploy up to $40 billion of financial capacity over five years across four growth platforms, with approximately 70% directed to growth initiatives.
- Continue M&A pipeline in aggregates, cementitious, road, and water segments as opportunities arise.
- Execute large road projects such as I-95 widening and reindustrialization contracts including chip plants and data centers.
- Maintain the winter-fill program to secure asphalt supply and cost advantages in the roads business.
Related earnings events
Basic MaterialsSources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-29T14:21:46.762437+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T14:21:46.759447+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.